Shares of Avacta Group Plc (LON:AVCT – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 43 ($0.54) and last traded at GBX 43 ($0.54), with a volume of 2035236 shares changing hands. The stock had previously closed at GBX 44.70 ($0.56).
Avacta Group Stock Down 3.8 %
The stock has a 50 day moving average price of GBX 50.38 and a 200 day moving average price of GBX 94.09. The company has a market cap of £154.39 million, a P/E ratio of -477.78 and a beta of 1.20. The company has a debt-to-equity ratio of 191.87, a quick ratio of 4.96 and a current ratio of 0.62.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- How to Invest in Small Cap Stocks
- Roblox: The Bottom Just Fell Out of the Metaverse
- Financial Services Stocks Investing
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
